Deerfield Management Company »

ACADIA Pharmaceuticals shares owned by Deerfield Management Company

Quarter-by-quarter ownership of ACADIA Pharmaceuticals (ACAD) shares owned by Deerfield Management Company from 13F filings

Historical chart of Deerfield Management Company investment in ACADIA Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including ACADIA Pharmaceuticals held by Deerfield Management Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in ACADIA Pharmaceuticals by Deerfield Management Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $305k 9.7k 31.31
2015-03-31 $1.6M 49k 32.59
2013-06-30 $19M 1.1M 18.15

More positions owned by Deerfield Management Company

Nuvalent Inc-a (NUVL)
Glaukos Corp Note 2.750% 6/1 (Principal)
Viatris (VTRS)
Invitae Corp Debt 4.500% 3/1 (Principal)
Natera Note 2.250% 5/0 (Principal)
Catalyst Pharmaceutical Partners (CPRX)
Centene Corporation (CNC)
Brookdale Sr Living Note 2.000%10/1 (Principal)
Insmed Note 1.750% 1/1 (Principal)
Neurocrine Biosciences (NBIX)
Accolade Note 0.500% 4/0 (Principal)
Oscar Health Cl A (OSCR)
Owens & Minor (OMI)
Adapthealth Corp Common Stock (AHCO)
Springworks Therapeutics (SWTX)

View all positions for Deerfield Management Company

Top funds holding ACADIA Pharmaceuticals

Baker Bros. Advisors
Vanguard Group
EcoR1 Capital
T. Rowe Price Associates
D. E. Shaw & Co
Fred Alger Management
Palo Alto Investors
Millennium Management
Emerald Advisers
Norges Bank Investment Management
Jupiter Asset Management
Emerald Mutual Fund Advisers, Trust
Voloridge Investment Management
Charles Schwab Investment Management
Deutsche Bank Aktiengesellschaft

View all funds holding ACADIA Pharmaceuticals